Technical Analysis for ORIC - Oric Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 22.0 7.32% 1.50
ORIC closed up 7.32 percent on Thursday, October 29, 2020, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ORIC trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
180 Bearish Setup Bearish Swing Setup 7.32%
NR7 Range Contraction 8.21%
NR7-2 Range Contraction 8.21%
Lower Bollinger Band Touch Weakness 8.21%
NR7 Range Contraction 2.85%
Stochastic Reached Oversold Weakness 2.85%
Inside Day Range Contraction 2.85%
Oversold Stochastic Weakness 2.85%
MACD Bearish Centerline Cross Bearish 8.27%
Older End-of-Day Gignals for ORIC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Gap Up Closed about 16 hours ago
Gap Up Partially Closed about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
Gapped Up (Full) about 16 hours ago
10 DMA Resistance about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. Its lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. The company's second product candidate is ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. It is also developing multiple precision medicines targeting other cancer resistance mechanisms. The company was founded in 2014 and is headquartered in South San Francisco, California.
Medicine Biopharmaceutical Health Cancer Clinical Medicine Treatment Of Cancer Immunotherapy Solid Tumors Cancers Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Specialty Drugs Antineoplastic Drugs Cancer Therapeutics Treatment Of Cancers

Is ORIC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.67
52 Week Low 18.6
Average Volume 98,795
200-Day Moving Average 0.00
50-Day Moving Average 22.83
20-Day Moving Average 22.96
10-Day Moving Average 22.26
Average True Range 2.10
ADX 16.49
+DI 16.98
-DI 22.06
Chandelier Exit (Long, 3 ATRs ) 20.18
Chandelier Exit (Short, 3 ATRs ) 25.53
Upper Bollinger Band 26.19
Lower Bollinger Band 19.73
Percent B (%b) 0.35
BandWidth 28.16
MACD Line -0.42
MACD Signal Line -0.21
MACD Histogram -0.2165
Fundamentals Value
Market Cap 678.21 Million
Num Shares 30.8 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 3.21
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.60
Resistance 3 (R3) 25.41 24.01 25.00
Resistance 2 (R2) 24.01 23.10 24.11 24.80
Resistance 1 (R1) 23.01 22.53 23.51 23.20 24.60
Pivot Point 21.61 21.61 21.87 21.71 21.61
Support 1 (S1) 20.61 20.70 21.11 20.80 19.40
Support 2 (S2) 19.21 20.13 19.31 19.20
Support 3 (S3) 18.21 19.21 19.00
Support 4 (S4) 18.40